PLOZURTTI
Live / Allowed — Publication / registration review complete (as of 09 Sept 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 06 Mar 2026 filing date already counts against anyone who files later.
Record
- Serial number
- 99687905
- Mark type
- Stylized text
- Filed
- 06 Mar 2026
- Published for opposition
- 29 Sept 2026
- Attorney of record
- Palak Mayani
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment and prevention of bone, cardiovascular, central nervous system, dermatological, endocrine, hematological, hepatological, immunological, gastrointestinal, genitourinary, gynecological, metabolic, musculoskeletal, nephrological, neurological, oncological, ophthalmic, retinal, psychiatric, pulmonary, renal, respiratory, and urological diseases and disorders; Pharmaceutical preparations for the treatment and prevention of autoimmune diseases, asthma, cancer and tumors, chronic cough, diabetes, hypertension, insomnia, intestinal infections, skin disorders, and urinary incontinence; Inhalers filled with pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Anti-infectives; Anti-inflammatories; Antiparasitics; Antivirals; Human vaccine preparations
Owner
- Merck Sharp & Dohme B.V., HAARLEM, NL
Prosecution history
- 02 Sept 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 07 Aug 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 03 Aug 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 03 Aug 2026 — TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
- 23 Jun 2026 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
- 23 Jun 2026 — LETTER OF SUSPENSION E-MAILED
- 23 Jun 2026 — SUSPENSION LETTER WRITTEN
- 17 Jun 2026 — ASSIGNED TO EXAMINER
- 06 Mar 2026 — APPLICATION FILING RECEIPT MAILED
- 06 Mar 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 06 Mar 2026 — NEW APPLICATION ENTERED